Novartis receives positive CHMP opinion for Kesimpta®* (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis

by NASDAQ Market News January 29, 2021

NASDAQ Market News
Click here to email author

ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults*

Global Fluoroscopy Equipment Market – Growing demand for data – integrated imaging systems, Advantages of FPDs over image intensifiers driving market growth – by PMI

Ads